A

Alto Neuroscience
D

ANRO

26.820
USD
-0.42
(-1.54%)
مغلق
حجم التداول
7,097
الربح لكل سهم
-3
العائد الربحي
-
P/E
-11
حجم السوق
1,042,503,484
المقالات
المزيد

العنوان: Alto Neuroscience

القطاع: Healthcare
الصناعة: Biotechnology
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.